منابع مشابه
Strategies for Cancer Vaccine Development
Treating cancer with vaccines has been a challenging field of investigation since the 1950s. Over the years, the lack of effective active immunotherapies has led to the development of numerous novel strategies. However, the use of therapeutic cancer vaccines may be on the verge of becoming an effective modality. Recent phase II/III clinical trials have achieved hopeful results in terms of overa...
متن کاملPrime-boost strategies for malaria vaccine development.
Malaria is an intracellular pathogen, for which an effective vaccine is likely to require induction of cell-mediated immunity. Immunisation approaches that stimulate strong and persistent levels of effector T-cells are being sought by many researchers. DNA vaccines, recombinant protein and viral vectors were amongst the vaccine delivery systems that appeared promising for the generation of cell...
متن کاملAlternative Vaccine Strategies for Cervical Cancer
Cervical cancer, caused by Human Papillomavirus (HPV) is the third largest cause of female mortality over the world with an estimated 500,000 cases and 270,000 deaths annually [1]. Nevertheless there are only two vaccines are available in the world market to protect cervical cancer. Gardasil® (Merck, USA)) and Cervarix® (GlaxoSmithKline, UK) are both Virus Like Particle (VLP) based vaccines and...
متن کاملBacterial otitis media: current vaccine development strategies.
Otitis media is the most common reason for children less than 5 years of age to visit a medical practitioner. Whilst the disease rarely results in death, there is significant associated morbidity. The most common complication is loss of hearing at a critical stage of the development of speech, language and cognitive abilities in children. The cause and pathogenesis of otitis media is multifacto...
متن کاملCurrent concepts in cancer vaccine strategies.
Cancer vaccines are entering a new phase of popularity, in part because of the recognition of when a therapeutic vaccine is most effective and the identification of appropriate target antigens. New technologies, most notably gene transfection into dendritic cell and DNA vaccination approaches, have spurred further clinical evaluations. While many researchers consider humoral responses as not be...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Biomedicine and Biotechnology
سال: 2010
ISSN: 1110-7243,1110-7251
DOI: 10.1155/2010/596432